The US-based Association of Clinical Research Organizations (ACRO) has joined national grouping the Coalition of Small Business Innovators (CSBI), citing the need to ensure funding for emerging research-intensive companies in the biopharmaceutical and medical device sectors.
CSBI, whose members include the Advanced Medical Technology Association, the Biotechnology Industry Organization, the Medical Device Manufacturers Association and the Neurotechnology Industry Organization, is a non-partisan coalition of organisations dedicated to fostering sustained private investment in small, highly innovative companies focusing on the development of new technologies.
The Coalition wants to see policies, such as revisions to the R&D tax credit, that will attract more capital to research-intensive innovation, with the broader aim of maintaining American competitiveness in a global market, encouraging investment in the US, and creating and sustaining domestic employment.
“Clinical research organisations essentially constitute the infrastructure for the development of new medical therapies and technologies for many start-up biopharmaceutical and device companies,” commented John Lewis, vice president of public affairs at ACRO.
“Too often, our members see the development of promising new therapies delayed or abandoned because of a lack of funding.”
The Association of Clinical Research Organizations provides representation globally for companies offering a range of specialized services to support the development of new pharmaceuticals, biologics and medical devices.
